Zujun Fang

682 total citations
38 papers, 523 citations indexed

About

Zujun Fang is a scholar working on Surgery, Molecular Biology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Zujun Fang has authored 38 papers receiving a total of 523 indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Surgery, 16 papers in Molecular Biology and 13 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Zujun Fang's work include Bladder and Urothelial Cancer Treatments (8 papers), Renal cell carcinoma treatment (7 papers) and Cancer and Skin Lesions (6 papers). Zujun Fang is often cited by papers focused on Bladder and Urothelial Cancer Treatments (8 papers), Renal cell carcinoma treatment (7 papers) and Cancer and Skin Lesions (6 papers). Zujun Fang collaborates with scholars based in China, United States and Austria. Zujun Fang's co-authors include Qiang Ding, Haowen Jiang, Zhong Wu, Peng Gao, Guowei Xia, Hui Wen, Chenchen Feng, Qiang Ding, Guanxiong Ding and Zhihua Kang and has published in prestigious journals such as PLoS ONE, The American Journal of Surgical Pathology and Cancer Letters.

In The Last Decade

Zujun Fang

36 papers receiving 511 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Zujun Fang China 13 258 139 135 98 93 38 523
B. Vokaer Belgium 11 191 0.7× 82 0.6× 168 1.2× 23 0.2× 48 0.5× 19 682
Evdokia Arkoumani Greece 12 189 0.7× 74 0.5× 173 1.3× 52 0.5× 122 1.3× 21 481
Rui Batısta Portugal 16 280 1.1× 167 1.2× 192 1.4× 16 0.2× 81 0.9× 29 719
É. Frouin France 14 130 0.5× 64 0.5× 227 1.7× 80 0.8× 55 0.6× 52 670
Jacqueline R. Batanian United States 15 206 0.8× 61 0.4× 82 0.6× 82 0.8× 92 1.0× 56 568
Nagaharu Tsukiji Japan 16 259 1.0× 83 0.6× 252 1.9× 47 0.5× 67 0.7× 29 665
Terri Woo United States 7 135 0.5× 114 0.8× 129 1.0× 24 0.2× 31 0.3× 8 394
Pilar Hernández-Campo Spain 12 199 0.8× 91 0.7× 127 0.9× 191 1.9× 25 0.3× 16 889
Tatjana Mallano Germany 6 206 0.8× 45 0.3× 72 0.5× 25 0.3× 138 1.5× 7 528
Bridget Charbonneau United States 13 200 0.8× 57 0.4× 250 1.9× 30 0.3× 332 3.6× 17 795

Countries citing papers authored by Zujun Fang

Since Specialization
Citations

This map shows the geographic impact of Zujun Fang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Zujun Fang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Zujun Fang more than expected).

Fields of papers citing papers by Zujun Fang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Zujun Fang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Zujun Fang. The network helps show where Zujun Fang may publish in the future.

Co-authorship network of co-authors of Zujun Fang

This figure shows the co-authorship network connecting the top 25 collaborators of Zujun Fang. A scholar is included among the top collaborators of Zujun Fang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Zujun Fang. Zujun Fang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Gao, Peng, Zujun Fang, Danfeng Xu, et al.. (2023). Systematic evaluation of narrow‐sense validity of polygenic risk score for prostate cancer in a Chinese prostate biopsy cohort. Clinical Genetics. 103(6). 636–643.
2.
Xu, Chenyang, et al.. (2023). Cell-Free DNA, MicroRNAs, Proteins, and Peptides as Liquid Biopsy Biomarkers in Prostate Cancer and Bladder Cancer. Methods in molecular biology. 2695. 165–179. 3 indexed citations
3.
Lin, Xiaoling, Yishuo Wu, Fang Liu, et al.. (2021). A Germline Variant at 8q24 Contributes to the Serum p2PSA Level in a Chinese Prostate Biopsy Cohort. Frontiers in Oncology. 11. 753920–753920. 3 indexed citations
4.
Xu, Chenyang, Xiaoling Lin, Wei Qian, et al.. (2020). Genetic risk scores based on risk-associated single nucleotide polymorphisms can reveal inherited risk of bladder cancer in Chinese population. Medicine. 99(19). e19980–e19980. 3 indexed citations
5.
Liao, Limin, Ben Wan, Wei Li, et al.. (2016). Results of a randomized, double‐blind, active‐controlled clinical trial with propiverine extended release 30 mg in patients with overactive bladder. British Journal of Urology. 119(1). 148–157. 3 indexed citations
6.
Feng, Chenchen, Zuquan Xiong, Haowen Jiang, et al.. (2015). Genetic alteration in notch pathway is associated with better prognosis in renal cell carcinoma. BioFactors. 42(1). 41–48. 18 indexed citations
7.
Zheng, Jie, et al.. (2013). Evaluation of Urodynamic Findings Before and After Mid-Urethral Tape Sling Operation for Female Stress Urinary Incontinence. Journal of Minimally Invasive Gynecology. 20(4). 482–486. 4 indexed citations
8.
Wang, Ping, Dingwei Ye, Jianming Guo, et al.. (2013). Genetic score of multiple risk‐associated single nucleotide polymorphisms is a marker for genetic susceptibility to bladder cancer. Genes Chromosomes and Cancer. 53(1). 98–105. 30 indexed citations
9.
Wan, Ben, Wei Li, Keji Xie, et al.. (2012). Randomized clinical trial evaluating safety and efficacy of propiverine ER 30 mg and tolterodine ER 4 mg in the treatment of overactive bladder. 1 indexed citations
10.
Feng, Chenchen, Lujia Wang, Zhongwen Zhou, et al.. (2012). Positive KI67 and Periodic Acid-Schiff Mandates Wider Range of Excision in Scrotal Extramammary Paget's Disease. Dermatologic Surgery. 39(3). 381–386. 4 indexed citations
11.
Chen, Zhongqing, Weihong Ding, Ke Xu, et al.. (2012). The 1973 WHO Classification Is More Suitable than the 2004 WHO Classification for Predicting Prognosis in Non-Muscle-Invasive Bladder Cancer. PLoS ONE. 7(10). e47199–e47199. 33 indexed citations
12.
Wen, Hui, Chenchen Feng, Guanxiong Ding, et al.. (2012). Med19 promotes bone metastasis and invasiveness of bladder urothelial carcinoma via bone morphogenetic protein 2. Annals of Diagnostic Pathology. 17(3). 259–264. 30 indexed citations
13.
Zhang, Hu, et al.. (2012). Primary adenocarcinoma of the urinary bladder: a single site analysis of 21 cases. International Urology and Nephrology. 45(1). 107–111. 10 indexed citations
14.
Li, Bingkun, Liping Li, Xiang Wang, et al.. (2012). Frozen Section-Guided Wide Local Excision in the Treatment of Recurrent Scrotal Extramammary Paget’s Disease. Dermatology. 224(3). 231–235. 4 indexed citations
15.
Wen, Hui, et al.. (2009). Correlation of DNA repair genetic polymorphisms and non muscle-invasive bladder cancer risk. Zhonghua miniao waike zazhi. 30(5). 336–339. 1 indexed citations
16.
Xu, Ke, Zujun Fang, Jie Zheng, et al.. (2009). Intraoperative frozen biopsy in wide surgical excision of Paget's disease of the scrotum. Urologic Oncology Seminars and Original Investigations. 27(5). 483–485. 9 indexed citations
17.
Gu, Bin, Qiang Ding, Guowei Xia, et al.. (2009). Primary Bilateral Adrenal Non-Hodgkin's Lymphoma Associated With Normal Adrenal Function. Urology. 73(4). 752–753. 3 indexed citations
18.
Wen, Hui, Qiang Ding, Zujun Fang, Guowei Xia, & Jie Fang. (2009). Population study of genetic polymorphisms and superficial bladder cancer risk in Han-Chinese smokers in Shanghai. International Urology and Nephrology. 41(4). 855–864. 32 indexed citations
19.
Gao, Peng, Qiang Ding, Zhong Wu, Haowen Jiang, & Zujun Fang. (2009). Therapeutic potential of human mesenchymal stem cells producing IL-12 in a mouse xenograft model of renal cell carcinoma. Cancer Letters. 290(2). 157–166. 120 indexed citations
20.
Geng, Jiang, Jie Fan, Haowen Jiang, et al.. (2009). Elevated serum soluble Fas ligand is a promising marker of testicular toxicity induced by epirubicin in rats. Toxicology Letters. 186(2). 96–103. 9 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by B. Vokaer Breakdown of academic impact, for papers by Evdokia Arkoumani Breakdown of academic impact, for papers by Rui Batısta Breakdown of academic impact, for papers by É. Frouin Breakdown of academic impact, for papers by Jacqueline R. Batanian Breakdown of academic impact, for papers by Nagaharu Tsukiji Breakdown of academic impact, for papers by Terri Woo Breakdown of academic impact, for papers by Pilar Hernández-Campo Breakdown of academic impact, for papers by Tatjana Mallano Breakdown of academic impact, for papers by Bridget Charbonneau
Rankless by CCL
2026